Error: Could not add to watchlist. X
+ Watchlist

ThromboGenics NV

THR:BB
EN Brussels
5.01
EUR
0.26
4.97%
As of 10/20/2017
Open
5.43
Day Range
4.99 - 5.72
Volume
575,990
Previous Close
5.27
52Wk Range
2.50 - 5.87
1 Yr Return
72.59%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
5.43
Day Range
4.99 - 5.72
Volume
575,990
Previous Close
5.27
52Wk Range
2.50 - 5.87
1 Yr Return
72.59%
YTD Return
97.90%
Current P/E Ratio (TTM)
-
Earnings per Share (EUR) (TTM)
-1.66
Market Cap (m EUR)
180.652
Shares Outstanding (m)
36.094
Price/Sales (TTM)
30.95
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.11%
% Price Change
-0.53%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
ThromboGenics N.V. is a biopharmaceutical company focused on developing treatments for diabetic eye disease. The Company's R&D pipeline of disease modifying drug candidates focuses on diabetic retinopathy (DR) and diabetic macular edema (DME). ThromboGenics has disease-modifying molecules in its pipeline addressing all segments of the DR and DME market.
Address
Gaston Geenslaan 1
B-3001
Heverlee
Belgium
Phone
32-16-75-13-10
Show More